Mostrando 2 resultados de: 2
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(2)
ODS 3: Salud y bienestar(2)
ODS 5: Igualdad de género(2)
Origen
scopus(2)
Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer
ArticleAbstract: Context: Abiraterone acetate is a small-molecule cytochrome P450 17A1 (CYP17A1) inhibitor that is acPalabras claves:Autores:Arlt W., Attard G., Cassidy A.M., De Bono J.S., Dowsett M., Folkerd E., Hughes B.A., Oommen N.B., Reid A.H.M., Richard J. Auchus, Thompson E.Fuentes:scopusMolecular pathways: Inhibiting steroid biosynthesis in prostate cancer
ReviewAbstract: A significant proportion of castration-resistant prostate cancers (CRPC) remains driven by ligand acPalabras claves:Autores:Attard G., Ferraldeschi R., Richard J. Auchus, Sharifi N.Fuentes:scopus